Literature DB >> 7541648

Frequent loss of chromosome arm 1p DNA in parathyroid adenomas.

V L Cryns1, S M Yi, H Tahara, R D Gaz, A Arnold.   

Abstract

Two molecular defects have been described in parathyroid adenomas: rearrangement and overexpression of the PRAD1/cyclin D1 oncogene and allelic loss of chromosome 11 DNA, often including the multiple endocrine neoplasia type 1 (MEN1) putative tumor suppressor gene region. In an effort to identify additional parathyroid tumor suppressor genes, we examined 25 parathyroid adenomas for tumor-specific allelic loss of polymorphic DNA loci located near known or candidate tumor suppressor genes. Control leukocyte DNA from all 25 patients was heterozygous for 1 or more of the 9 chromosome 1 markers examined. Allelic loss at 1 or more of these informative loci on chromosome 1 was observed in 10 of 25 (40%) adenomas. Although many tumors lost extensive regions on chromosome 1, all but one of these tumors had allelic loss of distal 1p (1p32-pter); four tumors also lost loci on 1q. Allelic loss at 11q13, the site of the MEN1 gene, was detected in 5 of 21 (24%) informative cases, including 3 with 1p loss. In contrast, allelic loss was rarely observed at loci on 9q and 10p and was not observed at loci on 3p, 3q, 4p, 5q, 12q, 14q, 18q, 22q, or Xp. In summary, clonal allelic loss of loci on chromosome arm 1p is a frequent feature of parathyroid adenomas, implying that inactivation of a tumor suppressor gene(s) on 1p commonly contributes to their pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541648     DOI: 10.1002/gcc.2870130103

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  15 in total

1.  Patterns of chromosomal imbalances in parathyroid carcinomas.

Authors:  S Kytölä; F Farnebo; T Obara; J Isola; L Grimelius; L O Farnebo; K Sandelin; C Larsson
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36.

Authors:  C Williamson; A A Pannett; J T Pang; C Wooding; M McCarthy; M N Sheppard; J Monson; R N Clayton; R V Thakker
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

Review 3.  Genetics of endocrine and metabolic disorders: parathyroid.

Authors:  R V Thakker
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

4.  A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.

Authors:  D C Chung; A P Smith; D N Louis; F Graeme-Cook; A L Warshaw; A Arnold
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

5.  Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.

Authors:  S Hemmer; V M Wasenius; C Haglund; Y Zhu; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.

Authors:  F Cetani; E Pardi; E Vignali; S Borsari; A Picone; L Cianferotti; E Ambrogini; P Miccoli; A Pinchera; C Marcocci
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

7.  p53/MDM2 Pathway Aberrations in Parathyroid Tumors: p21(WAF-1) and MDM2 Are Frequently Overexpressed in Parathyroid Adenomas.

Authors:  Begona Arribas; Eva Cristobal; Jose A. Alcazar; Juan Tardio; Juan C. Matinez-Montero; Jose R. Polo; Rafael Carrion; Laura Gil; Marta Azanedo; Jose M. Rojas; Javier Menarguez
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

8.  Analysis of the Cycilin D1/p16/pRb Pathway in Parathyroid Adenomas.

Authors:  Eva Cristobal; Begona Arribas; Juan Tardio; Jose A. AIcazar; Juan C. Matinez-Montero; Rafael Carrion; Jose R. Polo; Laura Gil; Marta Azanedo; Jose M. Rojas; Javier Menarguez
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

9.  Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism.

Authors:  Trisha Dwight; Anne E Nelson; George Theodosopoulos; Anne Louise Richardson; Diana L Learoyd; Jeanette Philips; Leigh Delbridge; Jan Zedenius; Bin T Teh; Catharina Larsson; Deborah J Marsh; Bruce G Robinson
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

10.  Thymic carcinoids in multiple endocrine neoplasia type 1.

Authors:  B T Teh; J Zedenius; S Kytölä; B Skogseid; J Trotter; H Choplin; S Twigg; F Farnebo; S Giraud; D Cameron; B Robinson; A Calender; C Larsson; P Salmela
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.